Black Rock Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,764,881 shares of EYPT stock, worth $39.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,764,881
Previous 2,787,359
35.07%
Holding current value
$39.5 Million
Previous $57.6 Million
43.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
72.5MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$87.3 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$71.4 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$65 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$43.5 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$42.9 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $357M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...